Downregulation or mutation of components of the JAK/STAT pathway have demonstrated blockade of IFN-y signaling and tumoral non-response to IFN-y, suggesting its involvement in the anti-tumor response (137, 138). This evidence concerns the gene SOAT1 and neoplasm.